PAR 1.25% 20.3¢ paradigm biopharmaceuticals limited..

Sharewise Presentation 22/7/24, page-127

  1. 692 Posts.
    lightbulb Created with Sketch. 130
    I noted that statement too but dismissed it as more likely an attempt at open and full disclosure of all possibilities.

    Should things go south with the negotiations, a CR would be much more likely, but is currently not anticipated. Fair way to put it, I thought.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.